reports
National Australia Bank Limited: 1 director
A director at National Australia Bank Limited sold 31,000 shares at 35.352AUD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
ANZ Group Holdings Ltd: 1 director
A director at ANZ Group Holdings Ltd sold 9,034 shares at 30.890NZD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Westpac Banking Corporation: 1 director
A director at Westpac Banking Corporation maiden bought 6,615 shares at 32.398AUD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
- MarketLine Department
Suncorp Group Ltd - Company Profile and SWOT Analysis
Summary Suncorp Group Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Suncorp Group Limited (Suncorp) is a Trans-Tasman insurance group. The group's primary activities involve providing a range of insurance products and services. These include home, contents, motor, boa...
- MarketLine Department
Commonwealth Bank of Australia - Company Profile and SWOT Analysis
Summary Commonwealth Bank of Australia - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Commonwealth Bank of Australia (CBA) provides a wide range of retail, commercial, and corporate banking; private banking; funds management; superannuation; broking services; and insurance...
- MarketLine Department
Rural Bank Limited - Company Profile and SWOT Analysis
Summary Rural Bank Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Rural Bank Limited (Rural Bank), a division of Bendigo and Adelaide Bank Limited, is a provider of agricultural and retail banking solutions. It offers farm term loans, farm line of credits, seasonal...
- MarketLine Department
Kiwibank Ltd - Company Profile and SWOT Analysis
Summary Kiwibank Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Kiwibank Ltd (KBL), a subsidiary of Kiwi Group Holding Limited (KGHL), is a provider of personal, business, and international banking solutions. It offers debit, business credit, and credit cards; accounts...
- Maria Vara
- Oscar Haffen Lamm
End of coverage
From 5th February, we will no longer include in our research universe:Adaptimmune, ALK, argenx, Autolus, Cellectis, Galapagos, Hansa Biopharma, Heidelberg Pharma, Immatics, Immunocore, Ipsen, Moonlake Immunotherapeutics, Pharvaris, UCB, Vivoryon Therapeutics, Zealand Pharma, Nicox, GenSight Biologi
CLLS CELLECTIS ADS
ADAP ADAPTIMMUNE THERAPEUTICS ADS
ANZ AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED
HPHA HEIDELBERG PHARMA AG
COX NICOX SA
UCB UCB S.A.
HNSA HANSA BIOPHARMA AB
SIGHT GENSIGHT BIOLOGICS SA
ALSEN SENSORION SAS
ALKb ALK-ABELLO
ARGX ARGEN-X SE
AUTL AUTOLUS THERAPEUTICS ADS
IMCR IMMUNOCORE HOLDINGS ADS
PHVS PHARVARIS NV
MLTX MOONLAKE IMMUNOTHERAPEUTICS
IMTX IMMATICS
GLG GALAPAGOS
VVY VIVORYON THERAPEUTICS
Annual Financial Report
Westpac Banking Corporation / Key word(s): Annual Results Annual Financial Report 06.11.2023 / 16:55 CET/CEST Westpac Banking Corporation Westpac 2023 Group Annual Report The announcement can be viewed at: A copy of the above document has been submitted to the National Storage Mechanism. 6th November 2023 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of ...
- Charlotte Cervin
- Elisabeth Rudman
- Maria Rivas Escrigas
Australian Banks: Strong H1 2023 Results On Net Interest Income Growth...
DBRS Morningstar has published a commentary discussing large Australian banks’ recent H1 2023 results, including Australia and New Zealand Banking Group Limited, National Australia Bank Limited, and Westpac Banking Corporation. Key points include: • The three large Australian banks reported solid results in the first half of 2023 primarily driven by strong net interest income growth on the back of higher interest rates and solid new lending volume growth. • Credit costs increased for all th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.